We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Daily Stair Walking on Cardiovascular Health (IRMA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01293253
First Posted: February 10, 2011
Last Update Posted: October 31, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Lars L. Andersen, National Research Centre for the Working Environment, Denmark
  Purpose

Many adults find it difficult to perform physical exercise during leisure. The workplace may provide an optimal setting to encourage a healthier lifestyle. This study investigates the effect of daily stair walking at the workplace on cardiovascular health.

The main hypothesis is that daily stair walking for 10 weeks compared with a control group results in increased aerobic fitness.


Condition Intervention
Cardiovascular Health Behavioral: Stair walking

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Danish: Integreret Motion på Arbejdspladsen (IRMA) English: Implementation of Exercise at the Workplace

Further study details as provided by Lars L. Andersen, National Research Centre for the Working Environment, Denmark:

Primary Outcome Measures:
  • Aerobic fitness [ Time Frame: before and after the 10 week intervention ]
    Watt-max test on a Monark bicycle ergometer


Secondary Outcome Measures:
  • Blood pressure [ Time Frame: before and after the 10 week intervention ]
  • Questionnaire-based data [ Time Frame: before and after the 10 week intervention ]
    working conditions, perceived health, tiredness and energy, physical activity

  • Heart Rate Variability [ Time Frame: Before and after the 10 week intervention ]
    HRV during rest is measured during a standardized test (5 min supine, 5 minute upright, 5 minute supine)


Estimated Enrollment: 150
Study Start Date: March 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Stair walking
Participants of this group is encouraged to use the stairs for 10 minutes a day at the workplace
Behavioral: Stair walking
Participants of the stair group is encouraged to use the stairs for 10 minutes a day at the workplace. Participants of the control group receive a health examination before and after the intervention period, and are advised to stay active
Active Comparator: Control
Receives a health examination before and after the intervention period, and are advised to stay active
Behavioral: Stair walking
Participants of the stair group is encouraged to use the stairs for 10 minutes a day at the workplace. Participants of the control group receive a health examination before and after the intervention period, and are advised to stay active

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 67 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • office worker

Exclusion Criteria:

  • life threatening disease
  • pregnancy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01293253


Locations
Denmark
Lægemiddelstyrelsen
Copenhagen, Denmark, 2300
Sponsors and Collaborators
National Research Centre for the Working Environment, Denmark
Investigators
Principal Investigator: Lars L Andersen, PhD National Research Centre for the Working Environment, Denmark
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lars L. Andersen, Senior Researcher, PhD, National Research Centre for the Working Environment, Denmark
ClinicalTrials.gov Identifier: NCT01293253     History of Changes
Other Study ID Numbers: IRMA01
First Submitted: February 9, 2011
First Posted: February 10, 2011
Last Update Posted: October 31, 2011
Last Verified: October 2011